Al's Comment:

 This is a new type of testing - which is a little more advanced than just seeing which genes are present or mutated. This tells which genes are active and may be able to better tell which patients might benefit from particular medications than just using the genetic profiling.


Posted on: 10/26/2019

NYU Langone Health launches new molecular assay to identify patients with brain tumors

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!